We demonstrated that while PLX4032 inhibited ERK1/2 in BRAFV600E/K, it activated this signaling pathway in BRAFWT melanoma cells via stimulation of RAF1 in a RAS-independent manner. The gene discussed is RAF1; the disease is melanoma.